Authors:
Vandamme, AM
Houyez, F
Banhegyi, D
Clotet, B
De Schrijver, G
De Smet, KAL
Hall, WW
Harrigan, R
Hellmann, N
Hertogs, K
Holtzer, C
Larder, B
Pillay, D
Race, E
Schmit, JC
Schuurman, R
Shulse, E
Sonnerborg, A
Miller, V
Citation: Am. Vandamme et al., Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up, ANTIVIR TH, 6(1), 2001, pp. 21-39
Authors:
Su, J
Naghavi, MH
Jejcic, A
Horal, P
Furuta, Y
Wu, YP
Li, SL
Hall, WW
Goobar-Larsson, L
Svennerholm, B
Vahlne, A
Citation: J. Su et al., The tripeptide glycyl-prolyl-glycine amide does not affect the early stepsof the human immunodeficiency virus type 1 replication, J HUMAN VIR, 4(1), 2001, pp. 8-15
Authors:
Salemi, M
Strimmer, K
Hall, WW
Duffy, M
Delaporte, E
Mboup, S
Peeters, M
Vandamme, AM
Citation: M. Salemi et al., Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution, FASEB J, 15(2), 2001, pp. 276-278
Citation: J. Hodgson et al., Can district-wide audits improve primary care epilepsy management? An audit of seizure frequency recording, BR J GEN PR, 50(452), 2000, pp. 229-230
Citation: Jg. Thomson et al., Microvascular anastomosis using 2-octyl cyanoacrylate in the rat femoral artery - Open discussion, ANN PL SURG, 44(5), 2000, pp. 511-511
Authors:
Lewis, MJ
Novoa, P
Ishak, R
Ishak, M
Salemi, M
Vandamme, AM
Kaplan, MH
Hall, WW
Citation: Mj. Lewis et al., Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II), VIROLOGY, 271(1), 2000, pp. 142-154
Citation: Mj. Lewis et al., Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfectedindividuals, J IMMUNOL, 165(7), 2000, pp. 4127-4132
Authors:
Okada, Y
Sawa, H
Tanaka, S
Takada, A
Suzuki, S
Hasegawa, H
Umemura, T
Fujisawa, J
Tanaka, Y
Hall, WW
Nagashima, K
Citation: Y. Okada et al., Transcriptional activation of JC virus by human T-lymphotropic virus type I tax protein in human neuronal cell lines, J BIOL CHEM, 275(22), 2000, pp. 17016-17023
Authors:
Egan, JF
O'Leary, B
Lewis, MJ
Mulcahy, F
Sheehy, N
Hasegawa, H
Fitzpatrick, F
O'Connor, JJ
O'Riordan, J
Hall, WW
Citation: Jf. Egan et al., High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland, AIDS RES H, 15(8), 1999, pp. 699-705
Authors:
Salemi, M
Lewis, M
Egan, JF
Hall, WW
Desmyter, L
Vandamme, AM
Citation: M. Salemi et al., Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes, P NAS US, 96(23), 1999, pp. 13253-13258
Authors:
Eiraku, N
Hingorani, R
Ijichi, S
Machigashira, K
Gregersen, PK
Monteiro, J
Usuku, K
Yashiki, S
Sonoda, S
Osame, M
Hall, WW
Citation: N. Eiraku et al., Clonal expansion within CD4(+) and CD8(+) T cell subsets in human T lymphotropic virus type I-Infected individuals, J IMMUNOL, 161(12), 1998, pp. 6674-6680